Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 24, 1998

View Archived Issues

Evaluation of the analgesic potential of 1,2,6-IP3

Recombinant methioninase shows clinical efficacy in depleting serum methionine

Neurocrine Biosciences reveals new technology

Evaluation of anti-IgE therapy in patients with seasonal allergic rhinitis

The Liposome Company: FY 1997 highlights

Sponge-derived natural product shows promise as a new cancer therapeutic

Muscarinic cholinergic agents from American Home

Pharmacyclics: Q2 1998 highlights

CoCensys: Q4 and FY 1997 highlights

First corticosteroid dry powder inhaler launched in the U.S.

Floxin Otic launched in U.S.

CellPro to begin clinical evaluation of B-Cell Depletion System

Celgene: Q4 and year-end 1997 highlights

CPMP recommends European approval of Exelon

Termination of merger discussions between SKB and Glaxo Wellcome

Perkin-Elmer and PerSeptive Biosystems complete merger

Flobufen update

Positive phase I results reported for TCAR product for MS

New herpes collaboration between Astra and Medivir

Apollo licenses technologies from U. of Florida

Quinolone HIV integrase inhibitors prepared at Warner-Lambert

First potent and selective CB2 receptor antagonist developed at Sanofi

DBD meets with FDA to discuss dibromodulcitol progress

Abbott will market Orion's calcium sensitizer levosimendan

Diatide issued approvable letter for AcuTect by FDA

Diversa receives NCI grant for pharmaceutical research

PI-88 one step closer to clinical testing

UCSF receives green light to develop new breast cancer therapy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...